OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

OncoDaily
Feb 3, 2024, 22:05 | Insight
Andrius Žučenka: The results of our novel 4-drug regimen G-ACTIVE for FLT3 mutated relapsed/refractory acute myeloid leukemia
Andrius Žučenka, Hematologist, Researcher, Lecturer and PhD Candidate at Vilnius University Hospital Santaros Klinikos, made…
Feb 3, 2024, 17:12 | Positive
Naveen Pemmaraju: Thank you to Jane Fonda for helping us raise so much awareness for research on behalf of our patients with MPNs
Naveen Pemmaraju shared on X/Twitter: "It was amazing to spend a few quality moments with…
Feb 3, 2024, 17:09 | Societies
Chandler Park: Best parts of ASCO GU 2024
Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on LinkedIn: "Best…
Feb 3, 2024, 17:06 | Insight
Nirmala Bhoo Pathy: Wide gaps in cancer screening across South-East Asia and Western Pacific
Nirmala Bhoo Pathy, shared on LinkedIn: "Wide gaps in cancer screening across South-East Asia and…
Feb 3, 2024, 16:55 | Positive
Maria Babak: I am very proud to be part of the Department of Chemistry of City University of Hong Kong
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared on…
Feb 3, 2024, 16:52 | Blog
Shikha Jain: Roon's mission is to provide everyone with a trusted guide for health providing education
Shikha Jain shared on X: "If you haven't checked out the Roon app yet, you…
Feb 3, 2024, 16:46 | Blog
The 4th Armenian Oncology Congress has started - National Center of Oncology
National Center of Oncology (Armenia) shared on Facebook: A ''The 4th Armenian Oncology Congress has…
Feb 3, 2024, 16:42 | Blog
February 4th - honoring those who've battled, supporting those currently fighting, and remembering those we've lost
February 4th is World Cancer Day. On this day, we unite in the fight against…
Feb 3, 2024, 16:36 | Blog
Fola May: A major highlight of the Stand Up To Cancer Summit is the opportunity for research team members to come together
Fola May, Associate Director of UCLA Specialty Training and Advanced Research Program, posted on X/Twitter:…
Feb 3, 2024, 16:31 | Insight
Raul Cordoba: About Geriatric Hematology
Raul Cordoba, the Coordinator of the Lymphoma Unit at Jimenez Diaz Foundation University Hospital, Madrid, Spain,…
Feb 3, 2024, 14:54 | Insight
Sebastian Schmidt: The new study confirms that radiation-risk is absolutely acceptable in lung cancer screening
Sebastian Schmidt, Head of Strategy and Medical Affairs Computed Tomography at Siemens Healthineers, shared on…
Feb 3, 2024, 14:41 | Career
Mark Bunnage: Absolute delight to have Caroline Fox joining our team to lead Boston Research
Mark Bunnage, Senior Vice President and Head of Research at Vertex Pharmaceuticals, announced on LinkedIn:…
Feb 3, 2024, 14:25 | Opinion
Abha Agrawal: "Disparities" in how physicians and healthcare organizations get paid for care
Abha Agrawal, President and CEO of Lawrence General Hospital, shared on LinkedIn: "Over the last…
Feb 3, 2024, 14:19 | Insight
Nirmala Bhoo Pathy: Our new study outlines key metrics for tracking progress and ensuring quality cancer care in the low- and middle-income countries
Nirmala Bhoo Pathy shared on LinkedIn: "Our new study outlines key metrics for tracking progress and…
Feb 3, 2024, 14:03 | Blog
We wish our nurses the best of luck in presenting themselves at the international workshop dedicated to pediatric oncology - Pediatric Cancer and Blood Disorders Center of Armenia
Feb 3, 2024, 13:53 | Drugs
Talha Badar: Upfront immunotherapy with or without chemotherapy for precursor B-cell ALL
Talha Badar, Hematologist/Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter: "Upfront immunotherapy +/-…
Feb 3, 2024, 08:38 | Positive
Prof Elizabeth Molyneux, thank you for everything you have done and are still doing for children with cancer and their families in Malawi and sub-Saharan Africa - CANCaRe Africa
Feb 3, 2024, 08:27 | Blog
Aparna Parikh: A great challenge to synthesize the state of ctDNA in colorectal cancer in 12 min and put into context why COBRA was stopped
Aparna Parikh quoted a post by Girish Putcha, the Principal of Precision Medicine & Diagnostics,…
Feb 2, 2024, 18:01 | Blog
Richard Scolyer: Georgina and I deeply honoured to be named 2024 Australians of the Year!
Richard Scolyer, Co-medical director at the Melanoma Institute Australia, and Cojoint professor at the University of…
Feb 2, 2024, 17:53 | Blog
Laurence Albiges: Proud of Gustave Roussy GU group celebrating 20th anniversary GU24  
Laurence Albiges, Chair at Medical Oncology Department at Gustave Roussy, shared a post on X/Twitter:…
Feb 2, 2024, 17:49 | Blog
Renee Maria Saliby: Type and timing of antibiotics matters on outcomes of ICIs in patients with mUC
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana Farber, shared a post on X/Twitter:…
Feb 2, 2024, 17:47 | Blog
Patrick Hwu: This interesting strategy has potential implications for combination cancer immunotherapy
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared a post on X/Twitter: "Tumors can…
Feb 2, 2024, 17:39 | Blog
Wafik El-Deiry: This is the destruction of science as I know it
Wafik El-Deiry made the following post on LinkedIn: “No one can manufacture scientific truth. Biology…
Feb 2, 2024, 17:33 | Drugs
Day 3 of GU24 ASCO Highlights by Oncology Brothers
Oncology Brothers recently tweeted: "Day 3 of GU24 ASCO Highlights 1. KN564: Adj Pembro w/…
Feb 2, 2024, 17:21 | Blog
Global Summit on War and Cancer 2023: Zeena Salman's speech titled "Childhood Cancer in Gaza - an Acute-on-Chronic Crisis"
The 1st Global Summit on War and Cancer took place on 14 - 16 December,…
Feb 2, 2024, 15:04 | Blog
Sylvie Leotin: The pain I faced during my cancer motivated me to use my innovation expertise to develop solutions to improve healthcare delivery for everyone
Sylvie Leotin, Editorial Board Member at the Journal of Patient Experience, shared a post on…
Feb 2, 2024, 14:44 | Blog
Sewanti Limaye: Thank you for bringing Iylon Foundation to the world dear John Tarantino
Sewanti Limaye, Co-Founder of Iylon Precision Oncology, shared a post on X/Twitter: "When Sendurai Mani…
Feb 2, 2024, 14:33 | Blog
Bishal Gyawali: How strange the academic world is
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen's University, shared a post on X/Twitter: "Both…
Feb 2, 2024, 14:20 | Blog
Luz M. Cumba García: Thrilled to announce my new role as advisor at the U.S. Department of State, Office of Mexican Affairs
Luz M. Cumba García, Advisor (AAAS Science & Technology Policy Fellow) at the U.S. Department…
Feb 2, 2024, 13:56 | Career
David Tom Cooke: I am thrilled to share that I have been elected to the Board of Directors of The Society of Thoracic Surgeons
David Tom Cooke, Professor of Thoracic Surgery at the UC Davis Health, shared on LinkedIn:…
Feb 2, 2024, 12:51 | Career
Kimmie Ng: So excited to serve as Associate Editor at JAMA
Kimmie Ng, Associate Chief of the Division of Gastrointestinal Oncology at Dana- Farber Cancer Institute,…
Feb 2, 2024, 12:43 | Blog
Joseph McCollom: Dr. Ronit Elk discusses how much culture plays a role in patient engagement
Joseph McCollom, Gastrointestinal Medical Oncology Physician at Parkview Cancer Institute, recently posted on X: "Dr.…
Feb 2, 2024, 12:35 | Blog
Ulrika Årehed Kågström: UICC has released its World Cancer Day 2024 Equity Report
Quoting Ulrika Årehed Kågström on LinkedIn: "Union for International Cancer Control (UICC) has released its World Cancer…
Feb 2, 2024, 12:30 | Blog
Katsuaki Maehara: I have compiled a list of NSCLC drugs for 2024
Katsuaki Maehara, Director of Medical Education Colleagues, posted the following on X: "NSCLC Drug List…
Feb 2, 2024, 12:25 | Opinion
Bishal Gyawali: Want to get your mind blown about how insane cancer drug prices have become?
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X: "Want to…
Feb 2, 2024, 12:20 | Insight
Erman Akkus: Targeting p53 in cancer. Is it promising?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Targeting p53 in cancer…
Feb 2, 2024, 12:11 | Blog
Yousef Zakharia: Combining hypomethylating agent guadecitabine and IO in ccRCC
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post on…
Feb 2, 2024, 12:02 | Opinion
Douglas Flora: I’m here advocating for AI in healthcare every day because I truly believe there's no tool more powerful for accelerating clinical trials
Douglas Flora, Executive Medical Director, Oncology Service at St. Elizabeth Healthcare, shared a post by Bertalan Meskó,…
Feb 2, 2024, 06:15 | Blog
Priya Chudasama: Help us advance understanding and clinical care of cancer metastasis
Priya Chudasama, Group Leader at DKFZ German Cancer Research Center, recently shared on LinkedIn: ''Are…
Feb 2, 2024, 06:07 | Blog
President Biden’s PACT Act expanded lung cancer screenings for millions of veterans - White House Office of Science and Technology Policy
Quoting White House Office of Science and Technology Policy on X/Twitter: "President Biden’s PACT Act…
Feb 2, 2024, 05:57 | Blog
Mark Geyer: Tigen Pharma has formally agreed to partner with us in clinical development of our CAR T-cell product for AML
Mark Geyer, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, recently shared on X/Twitter:…
Feb 2, 2024, 05:47 | Blog
Jarushka Naidoo: Save the date for the 11th All-Ireland Lung Cancer Conference
Jarushka Naidoo recently shared on LinkedIn: "Save the date for the 11th All-Ireland Lung Cancer…
Feb 2, 2024, 05:39 | Blog
Tracy Gosselin: We celebrated the contributions of Roberto Lopez, Patient Care Technician in the Symptom Care Clinic
Tracy Gosselin, Chief Nurse Executive, Senior Vice President and Department Chair at Memorial Sloan Kettering…
Feb 1, 2024, 22:57 | Blog
Jill Feldman: In what universe is 4 - 6 loose stools a day considered tolerable???
Jill Feldman recently shared a post by Stacey Tinianov, Vice President of Patient Advocacy and Engagement…
Feb 1, 2024, 22:48 | Blog
Bishal Gyawali: Very fascinating interview in Endpoints News with Janet Woodcock as she retires from the FDA
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X: "Very fascinating…
Feb 1, 2024, 22:40 | Blog
Naveen Pemmaraju: Super spectacular India trip now completed!
Naveen Pemmaraju shared on X/Twitter: “Super spectacular India trip now completed! Many new memories & all-time…
Feb 1, 2024, 22:31 | Blog
Lynn M. Schuchter: Reflecting on the midpoint of my term as ASCO President
Lynn M. Schuchter shared on X: “As January concludes, I'm reflecting on the midpoint of…
Feb 1, 2024, 22:23 | Blog
Kirsty Duncan: Serving you from a different chair this morning
Kirsty Duncan shared on X: "Wishing you all a good start to the week. Even on…
Feb 1, 2024, 22:18 | Blog
Sunday is the deadline to apply for our CSO program manager position - Common Sense Oncology
Common Sense Oncology made the following post on X: "Last call! Sunday is the deadline…
Feb 1, 2024, 17:38 | Blog
With the generous support of 'Izmirlian' Charitable Foundation we have launched another phase of 'Providing Care for Children with Cancer' program - City of Smile Charitable Foundation
Feb 1, 2024, 17:34 | Blog
Margaret Foti: It is a great honor to work with Dr. Phil Sharp in the American Association for Cancer Research’s role as Scientific Partner for Stand Up to Cancer
Margaret Foti, Chief Executive Officer at the American Association for Cancer Research, posted on X/Twitter: "It…
Feb 1, 2024, 17:31 | Insight
Paolo Tarantino: Any agnostic approval should not stop efforts in biomarker discovery for ADCs
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter: "Of…
Feb 1, 2024, 17:27 | Blog
Your chance to be part of a cutting-edge kidney cancer research discussion - KidneyCAN
KidneyCAN posted on X/Twitter: "This Town Hall is your chance to be part of a…
Feb 1, 2024, 17:24 | Drugs
Day 2 of GU24 ASCO Highlights by Oncology Brothers
Oncology Brothers shared on their X/Twitter: "Day 2 of GU24 ASCO Highlights 1. UNITE: EV…
Feb 1, 2024, 17:14 | Insight
Sumanta K. Pal: She has developed what I think should be called the 'Bergerot QOL Index ' for kidney cancer
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
Feb 1, 2024, 15:42 | Opinion
Thomas Powles: Enfortumab Vedotin and Pembrolizumab shows broad spectrum of activity for Regional Recurrence, Progression-free survival and Overall Survival in all subgroups
Feb 1, 2024, 15:31 | Opinion
Jarushka Naidoo: Congrats to super fellow David McMahon on his paper addressing a timely topic in thoracic oncology
Jarushka Naidoo shared a post on her X/Twitter page: "Congrats to super fellow David McMahon…
Feb 1, 2024, 14:54 | Blog
Arielle Elkrief: Happy to share our paper - FMT as an effective treatment for refractory irColitis
Arielle Elkrief, Assistant Professor and Principal Scientist at University of Montreal, shared a post by…
Feb 1, 2024, 14:37 | Blog
Percy Lee: It’s not a one size fits all approach anymore given advances in all specialties
Percy Lee, Professor and Vice-Chair of Clinical Research at City of Hope, shared on LinkedIn:…
Feb 1, 2024, 14:12 | Blog
Amin Nassar: Our Multicenter Retrospective Cohort Study' is now out in JTO!
Amin Nassar, Hematology/oncology fellow at Yale University, shared a post on X/Twitter: "Pumped to share…
Feb 1, 2024, 14:05 | Blog
Vincent Rajkumar: Two major studies on Essential Thrombocythemia in Blood Cancer Journal each with 1000 patients
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Feb 1, 2024, 13:59 | Blog
Yelena Janjigian: Thank you Stand Up To Cancer and Torrey Coast Gemini foundation for the opportunity to lead this amazing team TARGETING IMMUNE EVASION IN GEC
Yelena Janjigian shared on X/Twitter: “Thank you Stand Up To Cancer and Torrey Coast Gemini…
Feb 1, 2024, 13:56 | Blog
Mara Antonoff: Something looked very familiar about the person in this image
Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery at MD Anderson Cancer Center, recently…
Feb 1, 2024, 13:52 | Blog
Yuki Saito: A pan-cancer landscape of driver alterations and their clinical actionability in Japanese patients
Yuki Saito, Postdoctoral researcher at Keisuke Kataoka Laboratory, shared a post by Keisuke Kataoka Laboratory…
Feb 1, 2024, 12:41 | Blog
Mark Lewis: I've heard it said that chemo dosing is the closest a medical oncologist can get to a surgeon's level of precision
Mark Lewis shared a post on X/Twitter: "I've heard it said that chemo dosing is the…
Feb 1, 2024, 11:52 | Blog
Aaron Goodman: Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
Aaron Goodman shared a post on X/Twitter: "Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy |…
Feb 1, 2024, 11:48 | Blog
Applications to MSK Cancer Center’s School of Radiation Therapy are now open through February 1
Memorial Sloan Kettering Cancer Center shared a post on their LinkedIn page: "Applications to Memorial…
Feb 1, 2024, 11:37 | Blog
Tracey O’Brien: Two of the best medical minds in Australia
Tracey O’Brien shared a post by Australian of the Year Awards on LinkedIn adding: “Truly…
Feb 1, 2024, 05:42 | Blog
Wafik El-Deiry: It is sad to watch the attacks on science and the targeting of scientists
Wafik El-Deiry made the following post on LinkedIn: “It is sad to watch the attacks…
Feb 1, 2024, 05:27 | Blog
Shweta Maniar: After attending the J.P. Morgan Healthcare Conference in San Francisco, I want to share some of my key takeaways
Shweta Maniar, Global Director, Healthcare and Life Sciences at Google, shared on their LinkedIn: ''After…
Feb 1, 2024, 05:16 | Blog
Zainab Shinkafi-Bagudu: First Ladies Against Cancer (FLAC) Launch Flagship Screening Clinic at Kebbi medical center
Zainab Shinkafi-Bagudu shared a post on LinkedIn: ''First Ladies Against Cancer (FLAC) Launch Flagship Screening…
Feb 1, 2024, 04:54 | Blog
Chris Boshoff: The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer
Feb 1, 2024, 01:15 | Blog
Congratulations to Dr. Sarah Cohen-Gogo on being elected the next Co-Chair of the Women Leaders in Paediatric Oncology Network! - International Society of Paediatric Oncology – SIOP
Feb 1, 2024, 00:42 | Career
Caroline Fox: I am thrilled to join Vertex Pharmaceuticals as Senior Vice President and Boston Research Site Head
Caroline Fox, SVP and Boston Research Site Head at Vertex Pharmaceuticals, made the following post…
Feb 1, 2024, 00:32 | Blog
SIOPE proudly presents the SIOPE Lifetime Achievement Award for our paediatric oncology community!  - European Society for Paediatric Oncology (SIOPE)
European Society for Paediatric Oncology (SIOPE) made the following post on LinkedIn: "SIOPE proudly presents…
Feb 1, 2024, 00:25 | Blog
Sewanti Limaye: Proud to be sharing that we have won an international investigator initiated project grant
Sewanti Limaye, Director Medical Oncology, Director Precision Oncology; Director Oncology Research at Sir H.N. Reliance…
Jan 31, 2024, 23:59 | Insight
Tanja Obradovic: Outstanding work from UK
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post by…
Jan 31, 2024, 18:33 | Stories
I met my incredible mentor, Dr. Maria Babak, at Harvard Medical School, who has been instrumental in shaping my career - Jemma Arakelyan via The Babak Lab
The Babak Lab shared on their LinkedIn page: "My name is Jemma Arakelyan. I am…
Jan 31, 2024, 18:28 | Drugs
Day 1 of GU24 ASCO Highlights by Oncology Brothers
Oncology Brothers shared on their X/Twitter page: "Day 1 GU24 ASCO Highlights 1. CONTAC02: Atezo/Cabo…
Jan 31, 2024, 18:22 | Blog
Hedley Lewis: The challenge of riding the Cape Town Cycle Tour on a Unicycle
Hedley Lewis, CEO of CHOC - Childhood Cancer Foundation SA, shared a post on LinkedIn:…
Jan 31, 2024, 18:14 | Blog
Jan-Henning Klusmann: We are thrilled to announce the 35th GPOH Kind-Philipp-Meeting
Jan-Henning Klusmann, Professor of Pediatrics at the Goethe University Frankfurt, shared a post on LinkedIn:…
Jan 31, 2024, 18:08 | Blog
Klaus Nachbaur's article written almost thirty years ago was a turning point in the treatment of many Armenian children with cancer - Yeolyan Hematology and Oncology Center
Jan 31, 2024, 18:01 | Blog
Alessandro Isidori: Every success only serves to bring about an even greater one
Alessandro Isidori, Hematologist at the Hematology and Stem Cell Transplant Center of the AORMN Hospital,…
Jan 31, 2024, 17:56 | Insight
Istvan Petak: Only computational solutions can overcome the challenge of genomic complexity
Istvan Petak, Adjunct Professor at University of Illinois Chicago, shared on LinkedIn: "Hello, Bangalore, India.…
Jan 31, 2024, 17:49 | Insight
Earle Burgess: Initial results from a small pilot study in late mCRPC where there are limited to no effective treatment options available
Earle Burgess, Genitourinary Oncologist at Atrium Health Levine Cancer, shared on LinkedIn: "Enfortumab vedotin is…
Jan 31, 2024, 15:56 | Blog
Tatiana Prowell: Leptomeningeal disease is one of the great unmet needs in oncology
Tatiana Prowell shared a post by Nancy Lin, Director of the Metastatic Breast Cancer Program at…
Jan 31, 2024, 15:42 | Blog
Thomas Powles: We need better biomarkers in Urothelial Carcinoma
Thomas Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "Microsatellite instability (MSIH)…
Jan 31, 2024, 15:28 | Blog
Jennifer Thalappillil: So excited to be joining the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute as a Scientist focused on scientific writing!
Jennifer Thalappillil, Scientific Writer at Dana-Farber Cancer Institute, shared a post on X/Twitter: "So excited…
Jan 31, 2024, 15:16 | Blog
María Natalia Gandur Quiroga: As always, Sumanta K. Pal's presentations are a masterclass
María Natalia Gandur Quiroga shared a post on X/Twitter: "Incredible insights from Sumanta K. Pal's…
Jan 31, 2024, 15:07 | Blog
Stephanie Chuang: Love when medical conferences make space for patient advocacy
Stephanie Chuang, Founder of The Patient Story, shared on X: “Love when medical conferences make…
Jan 31, 2024, 14:55 | Blog
BPDCN Awareness Day took place this week on January 23rd - The Video Journal of Hematological Oncology
The Video Journal of Hematological Oncology made the following post on X: “BPDCN Awareness Day took…
Jan 31, 2024, 14:46 | Blog
Peter Pisters: I am proud of the outstanding education programs offered by MD Anderson Cancer Centre
Peter Pisters, President of The University of Texas MD Anderson Cancer Centre, shared a post…
Jan 31, 2024, 14:31 | Blog
Naoto Ueno: Appreciate the opportunity to be interviewed for The ASCO Post by Jame Abraham
Naoto Ueno, Director at University of Hawai’i Cancer Center, shared a post by Jame Abraham,…
Jan 31, 2024, 14:14 | Blog
Elad Sharon: The hottest new ICI BOTENSILIMAB in Kidney Cancer
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Michael Serzan, Genitourinary…
Jan 31, 2024, 13:10 | Blog
Allison O'Neill: On April 15th come cheer on the Dana-Farber Marathon Team!
Allison O'Neill posted on X/Twitter: "Where will you be Monday April 15th? Come cheer on…
Jan 30, 2024, 20:14 | Blog
Janine Fuochi Huguenin: Who you are and where you live should not determine if you live
Janine Fuochi Huguenin, Campaign Manager at Union for International Cancer Control (UICC), shared a post…
Jan 30, 2024, 20:10 | Opinion
Erman Akkus: A very useful comprehensive review for daily practice
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: “Metastatic RCC, IO(+TKI) > Renal…
Jan 30, 2024, 19:42 | Opinion
Dena Battle: We need to assess financial burden in kidney cancer!
Dena Battle, Kidney Cancer Advocate Involved in Patient 2.0 and Health 2.0 Communities, posted the…
Jan 30, 2024, 19:35 | Blog
Assem Suleimenova: Implementers training at Centers for Disease Control and Prevention
Assem Suleimenova, Digital Health Project Manager at I-TECH, posted the following on LinkedIn: "Implementers training…
Jan 30, 2024, 19:29 | Blog
Vrouyr Bilemjian: We have developed a tumor targeting drug delivery systems
Vrouyr Bilemjian, Solutions and Strategy Consultant at Innoplexus, made the following post on LinkedIn: "Excited…
All: 16104 Posts: 11501 - 11600